INSULET CORP (PODD)

↓ Download CSV

CIK 0001145197 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, INSULET CORP reported revenue of $2.71B, up 30.7% from the prior year. The company was profitable, with a net margin of 9.1% and a gross margin of 71.6%. It held $3.19B in total assets against $1.68B in total liabilities.

Key ratios (FY2025)

71.6%
Gross margin
17.5%
Operating margin
9.1%
Net margin
16.3%
Return on equity
+30.7%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$2.71B$2.07B$1.70B$1.31B$1.10B$904.40M$463.77M$366.99M
Cost of Revenue$768.20M$625.90M$537.20M$499.70M$346.70M$322.10M$257.90M$193.60M$186.60M$155.90M
Gross Profit$1.94B$1.45B$1.16B$805.60M$752.10M$582.30M$480.30M$370.20M$277.20M$211.09M
Operating Income$473.80M$308.90M$220.10M$37.60M$126.00M$51.50M$50.00M$27.40M-$7.40M-$10.70M
Net Income$247.10M$418.30M$206.30M$4.60M$16.80M$6.80M$11.60M$3.30M-$26.80M-$28.88M
EPS (Diluted)$3.48$5.78$2.94$0.07$0.24$0.10$0.19$0.05$-0.46$-0.48
Total Assets$3.19B$3.09B$2.59B$2.25B$2.05B$1.87B$1.14B$928.70M$816.74M$456.65M
Total Liabilities$1.68B$1.88B$1.86B$1.77B$1.49B$1.27B$1.07B$716.60M$658.23M$393.50M
Shareholders' Equity$1.52B$1.21B$732.70M$476.40M$556.30M$603.60M$75.90M$212.10M$158.50M$63.10M
Cash & Equivalents$907.20M$213.70M$113.90M$272.58M$137.17M
Operating Cash Flow$569.30M$430.20M$145.70M$119.00M-$68.10M$84.00M$98.40M$35.90M$41.30M$15.91M
Capital Expenditures$191.60M$124.90M$75.60M$122.90M$111.90M$129.00M$163.70M$157.40M$73.80M$22.11M
Shares Outstanding70.39M70.20M69.91M69.51M69.18M66.02M62.69M59.19M58.32M57.46M